Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 203.47M | 201.81M | 191.48M | 177.24M | 168.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 203.47M | 201.81M | 191.48M | 177.24M | 168.49M |
| Cost of Revenue | 74.72M | 77.59M | 74.49M | 72.42M | 65.30M |
| Gross Profit | 128.75M | 124.22M | 116.99M | 104.81M | 103.20M |
| SG&A Expenses | 150.78M | 157.40M | 146.67M | 122.03M | 118.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 314.02M | 328.54M | 308.46M | 277.55M | 268.05M |
| Operating Income | -110.55M | -126.73M | -116.99M | -100.32M | -99.56M |
| Income Before Tax | -94.87M | -110.29M | -107.72M | -102.50M | -114.58M |
| Income Tax Expenses | 290.00K | 716.00K | 30.00K | 133.00K | 405.00K |
| Earnings from Continuing Operations | -95.16M | -111.01M | -107.75M | -102.63M | -114.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -95.16M | -111.01M | -107.75M | -102.63M | -114.99M |
| EBIT | -110.55M | -126.73M | -116.99M | -100.32M | -99.56M |
| EBITDA | -100.32M | -116.27M | -106.39M | -89.70M | -88.85M |
| EPS Basic | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 |
| Normalized Basic EPS | -0.45 | -0.58 | -0.54 | -0.60 | -0.43 |
| EPS Diluted | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 |
| Normalized Diluted EPS | -0.45 | -0.58 | -0.54 | -0.60 | -0.43 |
| Average Basic Shares Outstanding | 123.87M | 123.75M | 123.05M | 122.45M | 121.71M |
| Average Diluted Shares Outstanding | 123.87M | 123.75M | 123.05M | 122.45M | 121.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |